Failing Forward in Peripheral T-Cell Lymphoma.
作者信息
Mehta-Shah Neha, Horwitz Steven M
机构信息
Department of Medicine, Division of Oncology, Washington University School of Medicine in St Louis, St Louis, MO.
Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.
出版信息
J Clin Oncol. 2024 May 10;42(14):1599-1602. doi: 10.1200/JCO.23.02658. Epub 2024 Mar 26.
Abstract
摘要
相似文献
1
Failing Forward in Peripheral T-Cell Lymphoma.外周T细胞淋巴瘤的挫折中前行
J Clin Oncol. 2024 May 10;42(14):1599-1602. doi: 10.1200/JCO.23.02658. Epub 2024 Mar 26.
2
Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphoma.索拉非尼用于复发或难治性外周和皮肤T细胞淋巴瘤的初步研究。
Br J Haematol. 2014 Oct;167(1):141-4. doi: 10.1111/bjh.12944. Epub 2014 May 29.
3
Intradural extramedullary relapse of peripheral T-cell lymphoma, NOS.外周T细胞淋巴瘤，非特指型的硬脊膜内髓外复发
J Clin Exp Hematop. 2020;60(2):62-64. doi: 10.3960/jslrt.19024.
4
Peripheral T-Cell Lymphoma: The Beginning of the End of the Beginning.外周T细胞淋巴瘤：开端之终的起始
Hematol Oncol Clin North Am. 2017 Apr;31(2):xiii-xiv. doi: 10.1016/j.hoc.2017.01.001.
5
[Diagnosis and treatment of peripheral T-cell lymphoma].[外周T细胞淋巴瘤的诊断与治疗]
Nihon Rinsho. 2012 Apr;70 Suppl 2:519-24.
6
Skeletal muscle peripheral T-cell lymphoma.骨骼肌外周T细胞淋巴瘤
J Clin Oncol. 2008 Jan 20;26(3):501-3. doi: 10.1200/JCO.2007.14.2794.
7
[Long-term survival after nasal NK/T cell lymphoma].[鼻NK/T细胞淋巴瘤的长期生存情况]
Orv Hetil. 2008 Apr 27;149(17):801-5. doi: 10.1556/OH.2008.28330.
8
Peripheral T-cell lymphoma in a child with cutaneous involvement.一名患有皮肤受累的儿童外周T细胞淋巴瘤。
Pediatr Hematol Oncol. 2014 May;31(4):372-4. doi: 10.3109/08880018.2014.903448.
9
Anaplastic large-cell lymphoma and peripheral T-cell lymphoma: What can pediatricians and adult oncologists learn from each other?间变性大细胞淋巴瘤和外周T细胞淋巴瘤：儿科医生和成人肿瘤学家能从彼此身上学到什么？
Hematol Oncol. 2017 Jun;35 Suppl 1:70-75. doi: 10.1002/hon.2404.
10
[Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)].外周T细胞淋巴瘤，非特指型（PTCL-NOS）
Nihon Rinsho. 2014 Mar;72(3):512-8.
本文引用的文献
1
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas.一项关于罗米地辛联合吉西他滨、奥沙利铂和地塞米松治疗复发或难治性侵袭性淋巴瘤（以T细胞淋巴瘤为主）患者的I期研究。
Clin Lymphoma Myeloma Leuk. 2025 May;25(5):328-336. doi: 10.1016/j.clml.2024.11.015. Epub 2024 Dec 4.
2
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.罗米地辛联合环磷酰胺、多柔比星、长春新碱和泼尼松与环磷酰胺、多柔比星、长春新碱和泼尼松治疗未经治疗的外周 T 细胞淋巴瘤患者：Ro-CHOP 试验的最终分析。
J Clin Oncol. 2024 May 10;42(14):1612-1618. doi: 10.1200/JCO.23.01687. Epub 2024 Feb 16.
3
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.戈利替尼，一种选择性JAK1酪氨酸激酶抑制剂，用于治疗难治性或复发性外周T细胞淋巴瘤患者（JACKPOT8研究B部分）：一项单臂、多中心、2期研究。
Lancet Oncol. 2024 Jan;25(1):117-125. doi: 10.1016/S1470-2045(23)00589-2. Epub 2023 Dec 9.
4
Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma.罗米地辛联合来那度胺治疗未经治疗的外周 T 细胞淋巴瘤的多中心 2 期研究。
Blood Adv. 2023 Oct 10;7(19):5771-5779. doi: 10.1182/bloodadvances.2023009767.
5
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.CHOEP 联合来那度胺作为 II-IV 期外周 T 细胞淋巴瘤患者初始治疗的 II 期研究的最终结果。
Br J Haematol. 2023 Aug;202(3):525-529. doi: 10.1111/bjh.18885. Epub 2023 May 22.
6
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.TP53 突变可识别接受 CHOP 为基础的化疗的外周 T 细胞淋巴瘤的高危事件。
Blood Adv. 2023 Sep 12;7(17):5172-5186. doi: 10.1182/bloodadvances.2023009953.
7
Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet?结外周 T 细胞淋巴瘤：无化疗管理，我们做到了吗？
Blood Rev. 2023 Jul;60:101071. doi: 10.1016/j.blre.2023.101071. Epub 2023 Mar 3.
8
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice.基因表达特征可准确诊断常规临床实践中的外周 T 细胞淋巴瘤。
J Clin Oncol. 2022 Dec 20;40(36):4261-4275. doi: 10.1200/JCO.21.02707. Epub 2022 Jul 15.
9
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版：淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
10
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.T 细胞淋巴瘤，2.2022 年版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2022 Mar;20(3):285-308. doi: 10.6004/jnccn.2022.0015.
Zotero 插件